Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Neoadjuvant radioimmunotherapy in pancreatic cancer enhances effector T cell infiltration and shortens their distances to tumor cells.
Wang J, Gai J, Zhang T, Niu N, Qi H, Thomas DL 2nd, Li K, Xia T, Rodriguez C, Parkinson R, Durham J, McPhaul T, Narang AK, Anders RA, Osipov A, Wang H, He J, Laheru DA, Herman JM, Lee V, Jaffee EM, Thompson ED, Zhu Q, Zheng L. Wang J, et al. Among authors: parkinson r. Sci Adv. 2024 Feb 9;10(6):eadk1827. doi: 10.1126/sciadv.adk1827. Epub 2024 Feb 7. Sci Adv. 2024. PMID: 38324679 Free PMC article.
A phase II study of guadecitabine combined with irinotecan vs regorafenib or TAS-102 in irinotecan-refractory metastatic colorectal cancer patients.
Lee V, Parkinson R, Zahurak M, Cope L, Cercek A, Verheul H, Gootjes E, Lenz HJ, Iqbal S, Jones P, Baylin S, Rami V, Ahuja N, El Khoueiry A, Azad NS. Lee V, et al. Among authors: parkinson r. Int J Cancer. 2024 May 15;154(10):1794-1801. doi: 10.1002/ijc.34845. Epub 2024 Feb 5. Int J Cancer. 2024. PMID: 38312102 Clinical Trial.
A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma.
Heumann T, Judkins C, Li K, Lim SJ, Hoare J, Parkinson R, Cao H, Zhang T, Gai J, Celiker B, Zhu Q, McPhaul T, Durham J, Purtell K, Klein R, Laheru D, De Jesus-Acosta A, Le DT, Narang A, Anders R, Burkhart R, Burns W, Soares K, Wolfgang C, Thompson E, Jaffee E, Wang H, He J, Zheng L. Heumann T, et al. Among authors: parkinson r. Nat Commun. 2023 Jun 20;14(1):3650. doi: 10.1038/s41467-023-39196-9. Nat Commun. 2023. PMID: 37339979 Free PMC article.
Epidemiological waves - Types, drivers and modulators in the COVID-19 pandemic.
Harvey J, Chan B, Srivastava T, Zarebski AE, Dłotko P, Błaszczyk P, Parkinson RH, White LJ, Aguas R, Mahdi A. Harvey J, et al. Among authors: parkinson rh. Heliyon. 2023 May 3;9(5):e16015. doi: 10.1016/j.heliyon.2023.e16015. eCollection 2023 May. Heliyon. 2023. PMID: 37197148 Free PMC article.
Clinicopathologic Significance of Anterior Prostate Cancer: Comparison With Posterior Prostate Cancer in the Era of Multiparametric Magnetic Resonance Imaging.
Samaratunga H, Egevad L, Yaxley JW, Johannsen S, Le Fevre IK, Perry-Keene JL, Gianduzzo T, Chabert C, Coughlin G, Parkinson R, Kua B, Yaxley W, Delahunt B. Samaratunga H, et al. Among authors: parkinson r. Am J Surg Pathol. 2023 Jun 1;47(6):701-708. doi: 10.1097/PAS.0000000000002042. Epub 2023 Apr 14. Am J Surg Pathol. 2023. PMID: 37057830
195 results